The Delhi Police on Tuesday filed two cases related to alleged violations of the Model Code of Conduct (MCC) ahead of the ...

With both sides showing no signs of backing down, the renewed trade war threatens to further disrupt global supply chains and ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

The stock's fall snapped a two-day winning streak.

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

PTC Punjabi dominated UK Asian TV ratings on Sunday, while Utsav Plus and Sony TV shared the No.2 spot, according to exclusive data obtained by BizAsiaLive.com.

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...

PTC Inc. closed 5.46% short of its 52-week high of $203.09, which the company achieved on December 12th.

As the robotics field progresses and enters more industries, robotics stocks are becoming increasingly promising investments. With AI-driven advancements accelerating growth, now could be an opportune ...